The funding supports Arsenale’s mission to transform the $200 billion biomanufacturing market while driving a new industrial trajectory towards a sustainable, biology-driven future. Arsenale’s platform combines advanced lab and industrial-scale bioreactors with AI-driven software, optimizing fermentation processes and increasing the speed of scaling from lab to industrial scale.